In this trial, we searched the incidence of breast cancer among the patients complained of breast pain and control group referred to our clinic.
Between January 2017 and June 2018, 1884 patients who applied to our breast clinic were classified into two groups considering the exclusion criteria. Participants with routine-screening or control (group 1) and patients with mastalgia (group 2) were retrospectively evaluated.
A total of 1884 women were included in the research. Following exclusion criteria: The 'mastalgia group' comprised 646 patients who had a mean age of 43.4 and the control group 647 patients who had a mean age of 44.2. There was no statistically significant difference in age between control with breast pain groups. Mammography was performed in 45.9% of the control group and 39.1% of the mastalgia group, and US was performed in 90.7% of patients with the control group and 93.1% in the mastalgia group. There was a important correlation between the two groups concerning BIRADS classification in mammography. BI-RADS category was higher in mastalgia group. In both groups, five patients were found to have breast cancer. All patients who had breast cancer were non-cyclic in mastalgia group. The patients who had cancer; five in the control group and four in the mastalgia group were in the postmenopausal period, and one in the mastalgia group were in the premenopausal period.
There was no increase in the incidence of cancer in patients presenting with breast pain. However, most patients with breast pain are exposed to imaging methods to exclude the cancer suspicion.